2008
DOI: 10.1111/j.1365-2257.1990.tb00038.x
|View full text |Cite
|
Sign up to set email alerts
|

Differences between the effects of EDTA and citrate anticoagulants on platelet count and mean platelet volume

Abstract: Summary Platelet counts on whole blood samples collected into tripotassium salt of EDTA, trisodium citrate (Na3 citr), citrate phosphate dextrose adenine formula 1 (CPDA‐1) and acid citrate dextrose formula A (ACD‐A), all showed a statistically significant drop (P < 0.01) after 1 h standing at room temperature (RT) as compared with the immediate (within 30 min) counts. After 1 h the enumeration became stable in the EDTA samples but the drop continued up to 4–6 h in those samples taken into citrate. The decrea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
45
1

Year Published

2008
2008
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(49 citation statements)
references
References 19 publications
3
45
1
Order By: Relevance
“…For the blood sampling, we used tubes containing EDTA as an anticoagulant, which may have induced platelet swelling. The MPV levels measured in EDTA-preserved samples are reportedly higher than those measured in citrate-preserved samples, and MPV is known to increase on addition of EDTA to citrated samples at six hours after an analysis (27,28). Most samples in our hospital were measured within one hour; thus, the influence of EDTA as an anticoagulant in our analysis is negligible.…”
Section: Discussionmentioning
confidence: 88%
“…For the blood sampling, we used tubes containing EDTA as an anticoagulant, which may have induced platelet swelling. The MPV levels measured in EDTA-preserved samples are reportedly higher than those measured in citrate-preserved samples, and MPV is known to increase on addition of EDTA to citrated samples at six hours after an analysis (27,28). Most samples in our hospital were measured within one hour; thus, the influence of EDTA as an anticoagulant in our analysis is negligible.…”
Section: Discussionmentioning
confidence: 88%
“…Significantly lower values of HGB in citrate whole blood were the result of lower ability of HGB to oxidate in that anticoagulant. McShine et al (1990) proved that both human platelet count and mean volume (MPV) in citrate blood is significantly lower than in EDTA. Similar observations were made in 1996 by O'Malley et al who used a combination of EDTA and citrate.…”
Section: Resultsmentioning
confidence: 99%
“…[28][29][30][31] Five of our 27 patients experienced hematological toxicities including one case of grade IV thrombocytopenia at the total dose of 3.0 Â 10 12 VP, a patient whose baseline platelet count was 200 Â 10 9 per l, whereas the mean platelet volume (MPV) was 6.8 fl, much lower than the normal range (9.4-12.5 fl). Although the mean platelet volume measurements can be quite variable, 32 low mean platelet volume implies that inhibition of platelet production occurred before the H103 treatment. This patient recovered after platelet transfusion within 3 months after H103 treatment.…”
Section: Discussionmentioning
confidence: 99%